| 引用本文：熊鹰,谭亚莉,张新平.基层医疗卫生机构基本药物增补目录制定现状分析[J].中国卫生政策研究,2011,4(6):35-38 |
|
| 基层医疗卫生机构基本药物增补目录制定现状分析 |
| 投稿时间：2011-05-09 修订日期：2011-05-20 PDF全文浏览 HTML全文浏览 |
| 熊鹰1, 谭亚莉2, 张新平2 |
| 1.湖北经济学院;2.华中科技大学同济医学院医药卫生管理学院 |
| 摘要:目的：为各地制定调整基本药物增补目录提供信息和依据。方法：资料来源于全国18个省份官方公布的基层医疗卫生机构基本药物增补目录及相关文件；采用EXCEL和SPSS13.0进行数据的描述性分析。结果：各地在目录制定层级、目录分级、目录结构、目录来源及各类别药物具体纳入情况等差异很大。建议：以省为单位统一制定目录，并按医疗机构级别进行分级；进一步规范目录的内容书写和表达，并注明来源于医保甲类或乙类目录；将相似性较高的药品纳入基本药物增补目录的核心目录品种集。 |
| 关键词:基本药物 增补目录 层级 结构 |
|
| Analysis on the status quo of additional essential medicine list of primary health care institutions in China |
|
|
| Abstract:Objective: To supply information and evidence for optimizing additional essential medicine lists (AEMLs). Methods: The officially released AEMLs of 18 provinces and related files were used; EXCEL and SPSS13.0 were used to data entry and analysis. Results: There are great differences in the following aspects： the level of authority； the classification of the list health facilities； the structure of the list； the source of the list， and the volume and contents of medicines included. Recommedations: The AEMLs should be formulated at the provincial level and according to different levels of medical institutions; standardize the format of the list and indicate its sources of A or B health insurance medicine list. The similar medicines should be collected to the core assembly of AEMLs. |
| Key words:Essential medicine Additional list Level Structure |
| 摘要点击次数: 3873 全文下载次数: 4276 |
|
|
